Literature DB >> 29408153

Do medical marijuana laws reduce addictions and deaths related to pain killers?

David Powell1, Rosalie Liccardo Pacula2, Mireille Jacobson3.   

Abstract

Recent work finds that medical marijuana laws reduce the daily doses filled for opioid analgesics among Medicare Part-D and Medicaid enrollees, as well as population-wide opioid overdose deaths. We replicate the result for opioid overdose deaths and explore the potential mechanism. The key feature of a medical marijuana law that facilitates a reduction in overdose death rates is a relatively liberal allowance for dispensaries. As states have become more stringent in their regulation of dispensaries, the protective value generally has fallen. These findings suggest that broader access to medical marijuana facilitates substitution of marijuana for powerful and addictive opioids.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dispensaries; Medical marijuana; Mortality; Opioids; Pain killers; Substance abuse

Mesh:

Substances:

Year:  2018        PMID: 29408153      PMCID: PMC7867411          DOI: 10.1016/j.jhealeco.2017.12.007

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  38 in total

1.  State medical marijuana laws: understanding the laws and their limitations.

Authors:  Rosalie Liccardo Pacula; Jamie F Chriqui; Deborah A Reichmann; Yvonne M Terry-McElrath
Journal:  J Public Health Policy       Date:  2002       Impact factor: 2.222

2.  Persons registered for medical marijuana in the United States.

Authors:  Daniel W Bowles
Journal:  J Palliat Med       Date:  2012-01       Impact factor: 2.947

3.  Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.

Authors:  Marcus A Bachhuber; Brendan Saloner; Chinazo O Cunningham; Colleen L Barry
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

4.  State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally Injured Drivers.

Authors:  June H Kim; Julian Santaella-Tenorio; Christine Mauro; Julia Wrobel; Magdalena Cerdà; Katherine M Keyes; Deborah Hasin; Silvia S Martins; Guohua Li
Journal:  Am J Public Health       Date:  2016-09-15       Impact factor: 9.308

5.  The effects of medical marijuana laws on potency.

Authors:  Eric L Sevigny; Rosalie Liccardo Pacula; Paul Heaton
Journal:  Int J Drug Policy       Date:  2014-01-18

6.  Deaths: final data for 2010.

Authors:  Sherry L Murphy; Jiaquan Xu; Kenneth D Kochanek
Journal:  Natl Vital Stat Rep       Date:  2013-05-08

7.  Words Can Be Deceiving: A Review of Variation Among Legally Effective Medical Marijuana Laws in the United States.

Authors:  Rosalie Liccardo Pacula; Priscillia Hunt; Anne Boustead
Journal:  J Drug Policy Anal       Date:  2014-12

8.  Older, Less Regulated Medical Marijuana Programs Have Much Greater Enrollment Rates Than Newer 'Medicalized' Programs.

Authors:  Arthur Robin Williams; Mark Olfson; June H Kim; Silvia S Martins; Herbert D Kleber
Journal:  Health Aff (Millwood)       Date:  2016-03       Impact factor: 6.301

9.  RISKS AND PRICES: THE ROLE OF USER SANCTIONS IN MARIJUANA MARKETS.

Authors:  Rosalie Liccardo Pacula; Beau Kilmer; Michael Grossman; Frank J Chaloupka
Journal:  B E J Econom Anal Policy       Date:  2010-02-17

10.  Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D.

Authors:  Ashley C Bradford; W David Bradford
Journal:  Health Aff (Millwood)       Date:  2016-07-01       Impact factor: 6.301

View more
  78 in total

1.  Public health benefits from legalizing cannabis: both sides of the coin.

Authors:  Ian Mitchell
Journal:  CMAJ       Date:  2016-01-05       Impact factor: 8.262

2.  Is There Less Opioid Abuse in States Where Marijuana Has Been Decriminalized, Either for Medicinal or Recreational Use? A Clin-IQ.

Authors:  Aaron M Wendelboe; Richard Mathew; Tana Chongsuwat; Elizabeth Rainwater; Mark A Wendelboe; Elizabeth Wickersham; Ann F Chou
Journal:  J Patient Cent Res Rev       Date:  2019-10-28

3.  Recreational marijuana legalization and prescription opioids received by Medicaid enrollees.

Authors:  Yuyan Shi; Di Liang; Yuhua Bao; Ruopeng An; Mark S Wallace; Igor Grant
Journal:  Drug Alcohol Depend       Date:  2018-10-25       Impact factor: 4.492

4.  Good Samaritan harm reduction policy and drug overdose deaths.

Authors:  Danielle N Atkins; Christine Piette Durrance; Yuna Kim
Journal:  Health Serv Res       Date:  2019-02-11       Impact factor: 3.402

5.  Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.

Authors:  Benedikt Fischer; Cayley Russell; Jürgen Rehm; Pamela Leece
Journal:  J Public Health (Oxf)       Date:  2019-06-01       Impact factor: 2.341

6.  Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System.

Authors:  Cynthia I Campbell; Sujaya Parthasarathy; Kelly C Young-Wolff; Derek D Satre
Journal:  J Psychoactive Drugs       Date:  2017-04-20

7.  Qualifying Conditions Of Medical Cannabis License Holders In The United States.

Authors:  Kevin F Boehnke; Saurav Gangopadhyay; Daniel J Clauw; Rebecca L Haffajee
Journal:  Health Aff (Millwood)       Date:  2019-02       Impact factor: 6.301

8.  The Associations of Neighborhood Availability of Marijuana Dispensaries and DATA-2000 Waivered Providers with Hospital Stays Related to Opioids.

Authors:  Di Liang; Yuyan Shi
Journal:  Subst Use Misuse       Date:  2019-08-25       Impact factor: 2.164

9.  Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.

Authors:  Rahi Abouk; Rosalie Liccardo Pacula; David Powell
Journal:  JAMA Intern Med       Date:  2019-06-01       Impact factor: 21.873

10.  The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada.

Authors:  Jenna Valleriani; Rebecca Haines-Saah; Rielle Capler; Ricky Bluthenthal; M Eugenia Socias; M J Milloy; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.